Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Serafina Guadagnuolo
Observed name:
S. Guadagnuolo
Institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Istituto di Ematologia di Bologna
Observed institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Istituto di Ematologia di Bologna,
Novartis (Italy),
University of Bologna
ORCID:
0009-0001-3615-3848
Observed ORCID:
0009-0001-3615-3848
OpenAlex ID:
A5079031505
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells
2024
·
Gianluca Storci
, Francesco De Felice
, et al.
·
Journal of Clinical Investigation
·
38
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience
2021
·
Beatrice Casadei
, Lisa Argnani
, et al.
·
Cancers
·
37
PDF
Global Transcriptome Analysis Reveals Small RNAs Affecting Neisseria meningitidis Bacteremia
2015
·
Luca Fagnocchi
, Silvia Bottini
, et al.
·
PLoS ONE
·
36
PDF
Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicity
2023
·
Serena De Matteis
, Michele Dicataldo
, et al.
·
Frontiers in Immunology
·
17
Real-World Evidence of Brexucabtagene Autoleucel for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
2021
·
Gloria Iacoboni
, Kai Rejeski
, et al.
·
Blood
·
11
Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1
2017
·
Arianna Marini
, Omar Rossi
, et al.
·
PLoS ONE
·
9
PDF
Role of gut microbiome in the outcome of lymphoma patients treated with checkpoint inhibitors—The MicroLinf Study
2024
·
Beatrice Casadei
, Gabriele Conti
, et al.
·
Hematological Oncology
·
8
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity
2024
·
Rossana Di Staso
, Beatrice Casadei
, et al.
·
Annals of Hematology
·
6
PDF
Gut Microbiota Role in Response to Checkpoint Inhibitor Treatment in Patients with Relapsed/Refractory B-Cell Hodgkin Lymphoma: The MICRO-Linf Study
2021
·
Beatrice Casadei
, Serafina Guadagnuolo
, et al.
·
Blood
·
5
Predicting ICANS by means of plasma CAR‐T cell derived extracellular vesicles in patients undergoing infusion of anti‐CD19 CAR‐T cells
2023
·
F. De Felice
, G. Storci
, et al.
·
Hematological Oncology
·
1
PDF
Fdg‐pet Imaging and Radiomics in Response Assessment of Lymphoma Patients Undergoing Car T‐cell Therapy
2021
·
B. Casadei
, A. Paccagnella
, et al.
·
Hematological Oncology
·
1
PDF
Gut Microbiota Role in Response to Checkpoint Inhibitor Treatment in Patients With Relapsed/refractory B‐cell Hodgkin Lymphoma: an Interim Analysis From Micro‐linf Study
2021
·
B. Casadei
, S. Guadagnuolo
, et al.
·
Hematological Oncology
·
1
Author response for "Role of gut microbiome in the outcome of lymphoma patients treated with checkpoint inhibitors—The MicroLinf Study"
2024
·
Beatrice Casadei
, Gabriele Conti
, et al.
·
Publons reviews and discussion
Interaction between gut microbiome and immune checkpoint inhibitor treatment in lymphoma patients: Final results of the MICRO‐LINF study
2023
·
B. Casadei
, L. Argnani
, et al.
·
Hematological Oncology
PDF
Show more works
View as search
Works count:
14
Citation count:
170
H-index:
7
I10-index:
5
Year
Topic
Type